← FDA Drug Approvals (Drugs@FDA)

NORFLEX

NDA · New Drug Application · Sponsor: PAI HOLDINGS PHARM · Approved 1960-10-02

Drug application

FDA Application #

NDA013055

Application type

New Drug Application

Brand name

NORFLEX

Generic name

Orphenadrine Citrate

Active ingredients

ORPHENADRINE CITRATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

PAI HOLDINGS PHARM

First approval

1960-10-02

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown